logo

For the Inventor, By the Inventor

Lund, Sweden

Anders Eriksson

This inventor holds 14 USPTO granted patents and 5 published patent applications and 4 EPO patents, primarily in Chemical Compounds. Top assignees: Astrazeneca Ab, Bayer Schering Pharma Ag, Bayer Pharma Aktiengesellschaft. Active years: 2006-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anders Eriksson. Retrieved from https://idiyas.com/inventor/anders-eriksson-wma0ahi7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 7.1

 

Average Co-Inventor Count = 7.2

ph-index = 5

Forward Citations = 84(Granted Patents)


Company Filing History:

goldMedal14 out of 1,534 
 
Astrazeneca Ab
 patents
silverMedal4 out of 192 
 
Bayer Schering Pharma Ag
 patents
bronzeMedal3 out of 387 
 
Bayer Pharma Aktiengesellschaft
 patents
where one patent can have more than one assignee

Years Active: 2006-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Metalloproteinase Inhibitors
Indazoles
Glucocorticoid Modulators
Chemical Compounds
Phenyl Derivatives
Benzodioxinyl Derivatives
Sulphonamide Derivatives
Pharmaceutical Chemistry
14 patents (USPTO):Explore Patents
1. 9738632 - Phenyl and benzodioxinyl substituted indazoles derivatives (2017-08-22),
2. 9512110 - Phenyl and benzodioxinyl substituted indazoles derivatives (2016-12-06),
3. 8916600 - Phenyl and benzodioxinyl substituted indazoles derivatives (2014-12-23),
4. 8211930 - Phenyl and benzodioxinyl substituted indazoles derivatives (2012-07-03),
5. 8153673 - Metalloproteinase inhibitors (2012-04-10),
6. 8143290 - Chemical compounds 572 (2012-03-27),
7. 8030340 - Indazolyl sulphonamide derivatives useful as glucocorticoid modulators (2011-10-04),
8. 7754750 - Metalloproteinase inhibitors (2010-07-13),
9. 7728030 - Chemical compounds 572 (2010-06-01),
10. 7666892 - Metalloproteinase inhibitors (2010-02-23),
11. 7625934 - Metalloproteinase inhibitors (2009-12-01),
12. 7427631 - Metalloproteinase inhibitors (2008-09-23),
13. 7368465 - Metalloproteinase inhibitors (2008-05-06),
14. 7132434 - Metalloproteinase inhibitors (2006-11-07),

Title: The Innovative Contributions of Anders Eriksson

Introduction

Anders Eriksson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work primarily focuses on novel chemical compounds that have potential medicinal applications.

Latest Patents

One of Anders Eriksson's latest patents involves phenyl and benzodioxinyl substituted indazoles derivatives. This invention relates to novel indazolyl derivatives, which are crucial for developing pharmaceutical compositions. The patent outlines processes for preparing these derivatives and their use as medicaments, showcasing Eriksson's commitment to advancing medical science.

Career Highlights

Throughout his career, Anders Eriksson has worked with prominent companies such as AstraZeneca AB and Bayer Schering Pharma AG. His experience in these leading pharmaceutical firms has allowed him to contribute to various innovative projects and research initiatives.

Collaborations

Anders has collaborated with esteemed colleagues, including Matti Juhani Lepistö and Magnus Munck Af Rosenschöld. These partnerships have further enriched his research and development efforts in the pharmaceutical industry.

Conclusion

Anders Eriksson's work exemplifies the spirit of innovation in the pharmaceutical field. His numerous patents and collaborations highlight his dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…